Skip to content
Open access

Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E).

Oct 2026 · Future Oncology · pp. 1-7 · 0 citations · 13 references
Medicine

Abstract

CLINICAL TRIAL REGISTRATION jRCT2031230456 (https://jrct.mhlw.go.jp/latest-detail/jRCT2031230456).

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.